Financial News
AnaptysBio, Inc. - Common Stock (NQ: ANAB )
21.22
+1.93
(+10.01%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Press Releases about AnaptysBio, Inc. - Common Stock
![](https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png)
![](https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png)
![](https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png)
Anaptys to Present at the Guggenheim SMID Cap Biotech Conference
February 03, 2025
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://insight.notified.com/hs-fs/hubfs/NF%20Images/NF%20Email%20Assets/Notified-GlobeNewswire-Color-Large.png)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update
November 05, 2024
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys Named a BioSpace 2024 Best Places to Work Winner
November 07, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys Announces Third Quarter 2023 Financial Results and Provides Business Update
November 02, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
Anaptys Announces Participation in November Investor Conferences
November 01, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230924200315_argenxs-28-surge-promising-product-propel-investor.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
September 18, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio to Present at the Stifel 2023 Immunology and Inflammation Virtual Summit
September 12, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
From AnaptysBio, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.